ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,045.26
0.38%
US Tech 100
21,346.40
0.00%
Dow Jones
42,967.62
0.24%
Brent Oil
72.92
4.31%
Bitcoin
105,132.41
-0.75%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Spero Therapeutics Inc (SPRO) Quote

Spero Therapeutics Inc

Spero Therapeutics Inc (SPRO)

NASDAQ
2.89
0.00
(0.00%)
Closed June 13 4:00PM
15 min delayed - Upgrade to Realtime
0.00
0.00
(0.00%)
After Hours: -
15 min delayed - Upgrade to Realtime

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.89
Bid
2.85
Ask
2.90
Volume
-
0.00 Day's Range 0.00
0.5052 52 Week Range 3.06
Market Cap
161.582M
Previous Close
2.89
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
4,111,277
Shares Outstanding
55,910,641
Dividend Yield
-
PE Ratio
-2.36
Earnings Per Share (EPS)
-1.23
Revenue
47.98M
Net Profit
-68.57M

About Spero Therapeutics Inc

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is de... Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.sperotherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Spero Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRO. The last closing price for Spero Therapeutics was $2.89. Over the last year, Spero Therapeutics shares have traded in a share price range of $ 0.5052 to $ 3.06.

Spero Therapeutics currently has 55,910,641 shares outstanding. The market capitalization of Spero Therapeutics is $161.58 million. Spero Therapeutics has a price to earnings ratio (PE ratio) of -2.36.

Ask ADVFN Intelligence (AI)

SPRO Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
May 13 2025
SPRO (0.00%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 13 2025
SPRO (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
May 06 2025
SPRO (0.00%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 28 2025
SPRO (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3513.77952755912.543.062.4525550742.75125352CS
42.2211332.0526237110.66893.060.6303126448892.3945668CS
122.13280.2631578950.763.060.505241112772.35002445CS
261.79162.7272727271.13.060.505220936332.27782597CS
521.45100.6944444441.443.060.505211317732.19165CS
1561.858180.038759691.0323.180.505212465511.89608216CS
260-8.75-75.171821305811.6423.6390.50528551643.03106441CS

SPRO - Frequently Asked Questions (FAQ)

What is the current Spero Therapeutics share price?
The current share price of Spero Therapeutics is $ 2.89
How many Spero Therapeutics shares are in issue?
Spero Therapeutics has 55,910,641 shares in issue
What is the market cap of Spero Therapeutics?
The market capitalisation of Spero Therapeutics is USD 161.58M
What is the 1 year trading range for Spero Therapeutics share price?
Spero Therapeutics has traded in the range of $ 0.5052 to $ 3.06 during the past year
What is the PE ratio of Spero Therapeutics?
The price to earnings ratio of Spero Therapeutics is -2.36
What is the cash to sales ratio of Spero Therapeutics?
The cash to sales ratio of Spero Therapeutics is 3.37
What is the reporting currency for Spero Therapeutics?
Spero Therapeutics reports financial results in USD
What is the latest annual turnover for Spero Therapeutics?
The latest annual turnover of Spero Therapeutics is USD 47.98M
What is the latest annual profit for Spero Therapeutics?
The latest annual profit of Spero Therapeutics is USD -68.57M
What is the registered address of Spero Therapeutics?
The registered address for Spero Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Spero Therapeutics website address?
The website address for Spero Therapeutics is www.sperotherapeutics.com
Which industry sector does Spero Therapeutics operate in?
Spero Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.10
(0.00%)
0
AACGATA Creativity Global
$ 0.8231
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.36
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.13
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.10
(0.00%)
0
AACGATA Creativity Global
$ 0.8231
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.36
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.13
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.10
(0.00%)
0
AACGATA Creativity Global
$ 0.8231
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.36
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.13
(0.00%)
0

SPRO Discussion

View Posts
bikaver bikaver 1 week ago
SPRO.....Taking my 20% profit and moving on.
👍️0
glenn1919 glenn1919 1 week ago
SPRO..................................................https://stockcharts.com/h-sc/ui?s=SPRO&p=W&b=5&g=0&id=p86431144783
👍️0
bikaver bikaver 2 weeks ago
SPRO.....picked up 2.16's last week.....
👍️0
glenn1919 glenn1919 2 weeks ago
SPRO................................https://stockcharts.com/h-sc/ui?s=SPRO&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 weeks ago
SPRO........................................p/m
👍️0
makinezmoney makinezmoney 2 weeks ago
$SPRO: Firing off biggggggggg..... now $2.30

Nice of those to get in at $0.70 yesterday.


CONGRATS on that


GO $SPRO
👍️0
PinkPennies PinkPennies 2 weeks ago
SPRO news https://finance.yahoo.com/news/spero-therapeutics-gsk-announce-pivot-110000843.html
👍️0
EarningsCentral EarningsCentral 2 months ago
👍️0
Monksdream Monksdream 9 months ago
SPRO under $2
👍️0
Monksdream Monksdream 11 months ago
SPRO under $2
👍️0
Monksdream Monksdream 1 year ago
SPRO under $2
👍️0
Monksdream Monksdream 1 year ago
SPRO under $2
👍️0
glenn1919 glenn1919 1 year ago
SPRO...................................https://stockcharts.com/h-sc/ui?s=SPRO&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
SPRO 10Q due March 13
👍️0
Monksdream Monksdream 1 year ago
SPRO under $2
👍️0
Monksdream Monksdream 2 years ago
SPRO new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SPRO new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SPRO new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SPRO under $2
👍️0
Awl416 Awl416 2 years ago
News?
👍️0
m0n m0n 2 years ago
$SPRO YuuuuGE FDA News

Spero Therapeutics shares were up 14% at $1.62 after the company received written agreement from the U.S. Food and
Drug Administration, under a Special Protocol Assessment, on the design and size of its pivotal Phase 3 clinical trial
of tebipenem HBr in patients with complicated urinary tract infection, including acute pyelonephritis.
👍️0
81vette 81vette 2 years ago
Urinary tract infection drug,$66m reviewed up to 525m coming,royalties on sales is astronomical
👍️0
81vette 81vette 2 years ago
Pfizer paid $5m of $40 and $80m total coming for license agreement,many more deals coming ,some phase 3 trials near done OMG THE BIG DEALS COMING
👍️0
81vette 81vette 2 years ago
Look at the candle on this chart 6 month record high,now look back to see what happens with big vol
👍️0
81vette 81vette 2 years ago
Look at the candle on this chart 6 month record high,now look back to see what happens with big vol
👍️0
81vette 81vette 2 years ago
Relative vol up 28Xs ,buy vol up 1000s% I AM FOLLOWING THE $ ppl with big $ know something huge coming
👍️0
81vette 81vette 2 years ago
Relative vol up 28Xs ,buy vol up 1000s% I AM FOLLOWING THE $ ppl with big $ know something huge coming
👍️0
saigai saigai 2 years ago
ive had some strange experiences with stocks but this one has me baffled but not beaten..
👍️0
saigai saigai 2 years ago
someone just unloaded a boat load and or shorted same. halfway around the cape and battered by high winds but not going anywhere. i cant
👍️0
saigai saigai 2 years ago
they will short this back down to .80 at this rate . eff me
👍️0
saigai saigai 2 years ago
folks keep walking away.. day after day after day.. ill be here im lashed to the mast of this bark as we get blistered around the cape
👍️0
saigai saigai 3 years ago
damn heavy unloading
👍️0
saigai saigai 3 years ago
big volume crashing again.. and i thought i was smart.. hahahahahastill bullish
👍️0
saigai saigai 3 years ago
must be some kind of inside news. this keeps falling and i dont get it.. but too late now .. this is the hill i die on or
👍️0
saigai saigai 3 years ago
a little retail short covering for the green. ill take it
👍️0
saigai saigai 3 years ago
another day of heavy downside volume in the cards..not good
👍️0
saigai saigai 3 years ago
shorts in control
👍️0
StockLogistics StockLogistics 3 years ago
GSK believed in SPRO enough to pay over 60 million at once, when investors get the same belief level it would in theory skyrocket, risk/reward and forward expectations are supposed to partially drive share price along with cash available to reduce risk of dilution, cash which GSK provided.
👍️0
StockLogistics StockLogistics 3 years ago
GSK believed in SPRO enough to pay over 60 million at once, when investors get the same belief level it would in theory skyrocket, risk/reward and forward expectations are supposed to partially drive share price along with cash available to reduce risk of dilution, cash which GSK provided.
👍️0
saigai saigai 3 years ago
a little run into earnings. ill hold through it and beyond
👍️0
saigai saigai 3 years ago
https://finance.yahoo.com/news/spero-therapeutics-announces-closing-exclusive-130500913.html
👍️0
saigai saigai 3 years ago
maybe we get some interest from this
https://finance.yahoo.com/news/spero-therapeutics-inc-spro-expected-140102871.html
👍️0
saigai saigai 3 years ago
ill be here when the mkt cap is over a billion
👍️0
saigai saigai 3 years ago
https://finance.yahoo.com/news/spero-therapeutics-present-data-idweek-120500461.html
👍️0
saigai saigai 3 years ago
almost no pre opening trading...the waters have stilled.. it wont stay calm for long ..lets see which way it breaks
👍️0
saigai saigai 3 years ago
bought more i wont be bought off with impatience
👍️0
saigai saigai 3 years ago
enter the flipper
👍️0
saigai saigai 3 years ago
just when you have given up hope a volume burst and a price pop
👍️0
StockLogistics StockLogistics 3 years ago
Macd on one month about to cross lower unless they have premarket news, many will sell premarket without news so if they have something releasing it premarket would be best for loyal shareholders who would miss out on a new release later in the session.
👍️0
saigai saigai 3 years ago
ugly ugly day again....but in a sane world this is 10x the mkt cap it is today
👍️0

Your Recent History

NASDAQ
SPRO
Spero Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads